# OnCo record digene-hc2-hpv (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/digene-hc2-hpv/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "digene-hc2-hpv" ;
  schema:name "digene Hybrid Capture 2 (hc2) High-Risk HPV DNA Test"@en ;
  schema:alternateName "Hybrid Capture 2"@en, "hc2"@en, "Digene HPV test"@en, "HCII"@en, "hc2 High-Risk HPV DNA Test" ;
  schema:description "Qiagen's hybrid capture HPV test, approved by the FDA in 2003 for use with the Pap test in women 30 and older and for sorting out borderline Pap results."@en ;
  schema:url <https://onco.cc/drugs/digene-hc2-hpv/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P890064> ;
  onco:status "approved" ;
  onco:tag "test", "screening-test" ;
  onco:modality "HPV DNA test (hybrid capture, signal amplification) for cervical screening" ;
  onco:approval "US 1991: ViraType HPV DNA typing kit, the original approval of PMA P890064 under which the hybrid capture tests followed", "US 2003: High-risk HPV DNA test on cervical specimens: ASCUS triage and adjunctive screening with the Pap test in women 30 and older (PMA P890064/S009)" ;
  onco:related <https://onco.cc/drugs/cobas-hpv/>, <https://onco.cc/drugs/aptima-hpv/>, <https://onco.cc/collections/fda-device-databases/> ;
  onco:cancers <https://onco.cc/cancers/cervical/> ;
  onco:sections <https://onco.cc/fronts/early-detection/>, <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/hpv-testing/> ;
  onco:companies <https://onco.cc/companies/qiagen/> ;
  onco:terms <https://onco.cc/terms/cin-hsil/>, <https://onco.cc/terms/screening/> .